109 related articles for article (PubMed ID: 28624542)
1. Outcome and Clinical Significance of Immunophenotypic Markers Expressed in Different Treatment Protocols of Pediatric Patients With T-ALL in Developing Countries.
Sayed DM; Sayed HAR; Raslan HN; Ali AM; Zahran A; Al-Hayek R; Daama SA; Al-Saber A
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):443-449. PubMed ID: 28624542
[TBL] [Abstract][Full Text] [Related]
2. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
3. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
6. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15.
Inukai T; Kiyokawa N; Campana D; Coustan-Smith E; Kikuchi A; Kobayashi M; Takahashi H; Koh K; Manabe A; Kumagai M; Ikuta K; Hayashi Y; Tsuchida M; Sugita K; Ohara A
Br J Haematol; 2012 Feb; 156(3):358-65. PubMed ID: 22128890
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R; Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Mori T; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kiyokawa N; Kobayashi R; Horibe K; Tsurusawa M
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e34-e37. PubMed ID: 28538509
[TBL] [Abstract][Full Text] [Related]
9. [T-cell pediatric acute lymphoblastic leukemia: analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP].
Rives S; Estella J; Camós M; García-Miguel P; Verdeguer A; Couselo JM; Tasso M; Molina J; Gómez P; Fernández-Delgado R; Navajas A; Badell I;
Med Clin (Barc); 2012 Jul; 139(4):141-9. PubMed ID: 22459573
[TBL] [Abstract][Full Text] [Related]
10. Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies.
Stark B; Avrahami G; Nirel R; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S
Br J Haematol; 2009 Oct; 147(1):113-24. PubMed ID: 19694717
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
12. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Patrick K; Wade R; Goulden N; Mitchell C; Moorman AV; Rowntree C; Jenkinson S; Hough R; Vora A
Br J Haematol; 2014 Aug; 166(3):421-4. PubMed ID: 24708207
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis.
Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S
Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Fuhrmann S; Schabath R; Möricke A; Zimmermann M; Kunz JB; Kulozik AE; Ludwig WD; Schrappe M; Karawajew L; Ratei R
Br J Haematol; 2018 Oct; 183(1):96-103. PubMed ID: 30028023
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004.
Kamps WA; van der Pal-de Bruin KM; Veerman AJ; Fiocco M; Bierings M; Pieters R
Leukemia; 2010 Feb; 24(2):309-19. PubMed ID: 20016528
[TBL] [Abstract][Full Text] [Related]
17. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
[TBL] [Abstract][Full Text] [Related]
19. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia.
Borssén M; Haider Z; Landfors M; Norén-Nyström U; Schmiegelow K; Åsberg AE; Kanerva J; Madsen HO; Marquart H; Heyman M; Hultdin M; Roos G; Forestier E; Degerman S
Pediatr Blood Cancer; 2016 Jul; 63(7):1185-92. PubMed ID: 26928953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
